Medivir AB: Broad pipeline of clinical stage assets. Birinipant, a bivalent SMAC mimetic read out positive Ph 1/2 combo (keytruda) data; currently in Phase 2 MSS CRC with interim data in 4Q19. MIV-818 is in Phase 1/2 in advanced liver cancer indication with early POC Ph 1a data in 2Q19; Phase 1b to start in 4Q19. Remetinostat in Ph 2 ISS study for BCC, positive interim data announced in 2Q19. BD/licencing opportunities: Ph 3 ready MIV-711 for OA and Ph 3 ready remetinostat for CTCL.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase III
Disease Space
Anti-inflammatory, Oncology
Industry
Biotechnology
Listing
Europe, Public
Market Cap
100MM - 500MM
Website:
Address:
Lunastigen 7
Huddinge, SE-141 22
Sweden

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Management Access: SF 2020

San Francisco, CA, United States, January 13 – January 16, 2020

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.